Objective <p>To identify institutional and organizational determinants associated with the adoption of multidisciplinary tumor boards (MDTBs) in head and neck cancer management across diverse healthcare settings.</p> Methods <p>This cross-sectional analysis used data from 566 responses, corresponding to 457 unique centers across 101 countries participating in the IFOS–YO-IFOS global survey. Centers were categorized by income level, region, and case volume. Logistic regression identified predictors of systematic MDTB use.</p> Results <p>Among responding centers, MDTBs were systematic in 89.1% of North America, 88.9% of European and 87.5% of Oceanian centers, compared with 37.5% in Africa and 32.6% in MENA. High annual case volume (&gt; 200 cases/year) (OR = 3.4, <i>p</i> &lt; 0.001), university affiliation (OR = 2.7, <i>p</i> = 0.002), and access to intensity-modulated radiotherapy (OR = 2.1, <i>p</i> = 0.01) independently predicted full MDTB integration. Centers citing economic barriers showed a 65% reduction in odds of MDTB implementation.</p> Conclusions <p>Our findings suggest that multidisciplinary management in head and neck oncology is strongly influenced by institutional resources and organizational models rather than geography alone. Strengthening MDTB frameworks in low- and middle-income regions could substantially narrow global care inequities.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Predictors of multidisciplinary tumor board implementation in head and neck cancer: Global insights

  • Antonino Maniaci,
  • Jerome R. Lechien,
  • Carlos Chiesa-Estomba,
  • Victorine Maso,
  • Fiona Kabagenyi,
  • Isabelle Gengler,
  • Johannes J. Fagan,
  • Sheng Po Hao,
  • Luiz P. Kowalski,
  • Bernard Lyons,
  • Mohamad Yunus Mohd Razif,
  • Hani Z. Marzouki,
  • Federica Maria Parisi,
  • Matthew White,
  • Justin Michel,
  • Nicolas Fakhry

摘要

Objective

To identify institutional and organizational determinants associated with the adoption of multidisciplinary tumor boards (MDTBs) in head and neck cancer management across diverse healthcare settings.

Methods

This cross-sectional analysis used data from 566 responses, corresponding to 457 unique centers across 101 countries participating in the IFOS–YO-IFOS global survey. Centers were categorized by income level, region, and case volume. Logistic regression identified predictors of systematic MDTB use.

Results

Among responding centers, MDTBs were systematic in 89.1% of North America, 88.9% of European and 87.5% of Oceanian centers, compared with 37.5% in Africa and 32.6% in MENA. High annual case volume (> 200 cases/year) (OR = 3.4, p < 0.001), university affiliation (OR = 2.7, p = 0.002), and access to intensity-modulated radiotherapy (OR = 2.1, p = 0.01) independently predicted full MDTB integration. Centers citing economic barriers showed a 65% reduction in odds of MDTB implementation.

Conclusions

Our findings suggest that multidisciplinary management in head and neck oncology is strongly influenced by institutional resources and organizational models rather than geography alone. Strengthening MDTB frameworks in low- and middle-income regions could substantially narrow global care inequities.